))
FDA Drug Safety Podcast: FDA warns about rare occurrences of a serious infection of the genital area with SGLT2 inhibitors for diabetes
Archived series ("Inactive feed" status)
When?
This feed was archived on May 29, 2019 01:06 (
Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 216266421 series 1381764
Content provided by U.S. Food, Drug Administration, and Center for Drug Evaluation. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by U.S. Food, Drug Administration, and Center for Drug Evaluation or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
On August 29, 2018, FDA warned that cases of a rare but serious infection of the genitals and area around the genitals have been reported with the class of type 2 diabetes medicines called sodium-glucose cotransporter-2 (or SGLT2) inhibitors.
…
continue reading
12 episodes
Share
